ZYLOXTB Repurchases 55,000 Shares for HK$1.12 Million on September 11
Stock News
Sep 11
ZYLOXTB (02190) announced that on September 11, 2026, the company spent HK$1.1175 million to repurchase 55,000 shares.
The buyback reflects the company's ongoing commitment to enhancing shareholder value through strategic capital management. The repurchased shares are expected to be cancelled or held as treasury shares, subject to regulatory requirements and market conditions.
This move is part of the broader trend among Hong Kong-listed healthcare and medical device companies utilizing share repurchases to signal confidence in their business prospects and financial stability.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.